These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 29605802)

  • 1. Optical coherence tomography as a biomarker of neurodegeneration in multiple sclerosis: A review.
    Alonso R; Gonzalez-Moron D; Garcea O
    Mult Scler Relat Disord; 2018 May; 22():77-82. PubMed ID: 29605802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripapillary retinal nerve fiber layer thickness measured by optical coherence tomography in different clinical subtypes of multiple sclerosis.
    Jankowska-Lech I; Wasyluk J; Palasik W; Terelak-Borys B; Grabska-Liberek I
    Mult Scler Relat Disord; 2019 Jan; 27():260-268. PubMed ID: 30423530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal thickness as a potential biomarker of neurodegeneration and a predictor of early cognitive impairment in patients with multiple sclerosis.
    Esmael A; Elsherif M; Abdelsalam M; Sabry D; Mamdouh M; Belal T
    Neurol Res; 2020 Jul; 42(7):564-574. PubMed ID: 32370626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis.
    Zaveri MS; Conger A; Salter A; Frohman TC; Galetta SL; Markowitz CE; Jacobs DA; Cutter GR; Ying GS; Maguire MG; Calabresi PA; Balcer LJ; Frohman EM
    Arch Neurol; 2008 Jul; 65(7):924-8. PubMed ID: 18625859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical coherence tomography: A quantitative tool to measure neurodegeneration and facilitate testing of novel treatments for tissue protection in multiple sclerosis.
    Gordon-Lipkin E; Calabresi PA
    J Neuroimmunol; 2017 Mar; 304():93-96. PubMed ID: 28038893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early reduction of retinal thickness predicts physical and cognitive disability in newly diagnosed multiple sclerosis patients: results from a cross-sectional study.
    Toscano S; Chisari CG; Biondi A; Patti F
    Neurol Sci; 2024 Nov; 45(11):5385-5394. PubMed ID: 38951431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of retinal atrophy in multiple sclerosis: A longitudinal study using spectral domain optical coherence tomography with segmentation analysis.
    Behbehani R; Adnan H; Al-Hassan AA; Al-Salahat A; Alroughani R
    Mult Scler Relat Disord; 2018 Apr; 21():56-62. PubMed ID: 29459346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers.
    Coric D; Balk LJ; Verrijp M; Eijlers A; Schoonheim MM; Killestein J; Uitdehaag BM; Petzold A
    Mult Scler; 2018 Feb; 24(2):158-166. PubMed ID: 28273785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness.
    Saidha S; Syc SB; Durbin MK; Eckstein C; Oakley JD; Meyer SA; Conger A; Frohman TC; Newsome S; Ratchford JN; Frohman EM; Calabresi PA
    Mult Scler; 2011 Dec; 17(12):1449-63. PubMed ID: 21865411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corneal Confocal Microscopy: An Imaging Endpoint for Axonal Degeneration in Multiple Sclerosis.
    Petropoulos IN; Kamran S; Li Y; Khan A; Ponirakis G; Akhtar N; Deleu D; Shuaib A; Malik RA
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3677-3681. PubMed ID: 28727882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mathematical model to predict the evolution of retinal nerve fiber layer thinning in multiple sclerosis patients.
    Montolío A; Cegoñino J; Orduna E; Sebastian B; Garcia-Martin E; Pérez Del Palomar A
    Comput Biol Med; 2019 Aug; 111():103357. PubMed ID: 31326867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Cells in the Retinal Ganglion Cell Layer as an Early Indication of Neurodegeneration in Multiple Sclerosis.
    Shenoy N; Liu F; Narayanan SP
    J Integr Neurosci; 2024 Jul; 23(7):129. PubMed ID: 39082294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retinal atrophy using optical coherence tomography (OCT) in 15 patients with multiple sclerosis and comparison with healthy subjects].
    Jeanjean L; Castelnovo G; Carlander B; Villain M; Mura F; Dupeyron G; Labauge P
    Rev Neurol (Paris); 2008 Nov; 164(11):927-34. PubMed ID: 18808761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of retinal nerve fiber layer thickness measured by optical coherence tomography in Moroccan patients with multiple sclerosis.
    Soufi G; AitBenhaddou E; Hajji Z; Tazrout S; Benomar A; Soufi M; Boulanouar A; Abouqal R; Yahyaoui M; Berraho A
    J Fr Ophtalmol; 2015 Jun; 38(6):497-503. PubMed ID: 25896580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosis.
    Bsteh G; Hegen H; Teuchner B; Amprosi M; Berek K; Ladstätter F; Wurth S; Auer M; Di Pauli F; Deisenhammer F; Berger T
    Mult Scler; 2019 Feb; 25(2):196-203. PubMed ID: 29095097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical coherence tomography monitoring and diagnosing retinal changes in multiple sclerosis.
    Mehmood A; Ali W; Song S; Din ZU; Guo RY; Shah W; Ilahi I; Yin B; Yan H; Zhang L; Khan M; Ali W; Zeb L; Safari H; Li B
    Brain Behav; 2021 Oct; 11(10):e2302. PubMed ID: 34520634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal layer segmentation in patients with multiple sclerosis using spectral domain optical coherence tomography.
    Garcia-Martin E; Polo V; Larrosa JM; Marques ML; Herrero R; Martin J; Ara JR; Fernandez J; Pablo LE
    Ophthalmology; 2014 Feb; 121(2):573-9. PubMed ID: 24268855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying visual pathway axonal and myelin loss in multiple sclerosis and neuromyelitis optica.
    Manogaran P; Vavasour IM; Lange AP; Zhao Y; McMullen K; Rauscher A; Carruthers R; Li DKB; Traboulsee AL; Kolind SH
    Neuroimage Clin; 2016; 11():743-750. PubMed ID: 27330974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optical Coherence Tomography and Magnetic Resonance Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.
    Manogaran P; Hanson JV; Olbert ED; Egger C; Wicki C; Gerth-Kahlert C; Landau K; Schippling S
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal imaging and axonal degeneration in later onset multiple sclerosis.
    Huhn K; Lämmer R; Zimmermann H; Lämmer A; Waschbisch A; Utz K; Gieß RM; Paul F; Linker RA; Lee DH
    J Neurol Sci; 2016 Nov; 370():1-6. PubMed ID: 27772735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.